The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model
Open accessAbstract
Inflammation is a key pathological hallmark of Alzheimer’s disease (AD), although its impact on disease progression and neurodegeneration remains an area of active investigation. Among numerous inflammatory cytokines associated with AD, IL-1β in particular has been implicated in playing a pathogenic role. In this study, we sought to investigate whether inhibition of IL-1β signaling provides disease-modifying benefits in an AD mouse model and, if so, by what molecular mechanisms. We report that chronic dosing of 3xTg-AD mice with an IL-1R blocking Ab significantly alters brain inflammatory responses, alleviates cognitive deficits, markedly attenuates tau pathology, and partly reduces certain fibrillar and oligomeric forms of amyloid-β. Alterations in inflammatory responses correspond to reduced NF-κB activity. Furthermore, inhibition of IL-1 signaling reduces the activity of several tau kinases in the brain, including cdk5/p25, GSK-3β, and p38–MAPK, and also reduces phosphorylated tau levels. We also detected a reduction in the astrocyte-derived cytokine, S100B, and in the extent of neuronal Wnt/β-catenin signaling in 3xTg-AD brains, and provided in vitro evidence that these changes may, in part, provide a mechanistic link between IL-1 signaling and GSK-3β activation. Taken together, our results suggest that the IL-1 signaling cascade may be involved in one of the key disease mechanisms for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence suggests that the pathological activation of glial cells and the release of inflammatory factors involved in neuroinflammation can exacerbate tau pathology via direct or indirect pathways, leading to neuronal damage and cognitive impairment, ultimately aggravating AD pathology [113, 114].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [113]
In the citing paper
“First, the proinflammatory cytokines TNFα, IL1 β, and IL6 have been shown to promote tau phosphorylation in neurons (Bhaskar et al., 2010; Kitazawa et al., 2011; Quintanilla et al., 2004).”
From Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease (2018) · cites this paper as Kitazawa et al., 2011
In the citing paper
“IL-1 receptor signalling is found to play a key role in neuroinflammation-induced tau phosphorylation by enhancing the activity of tau kinases including cyclin-dependent-like kinase 5/p25 (CDK5/p25), glycogen synthase kinase 3β (GSK3β), and p38 mitogen-activated protein kinase (p38-MAPK)60,61.”
From Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight (2018) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 472
Pyroptosis in Alzheimer’s Disease: Mechanisms and Therapeutic Potential
Tang, T. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01579-5 · Cited by 17
Emerging roles for innate and adaptive immunity in tauopathies
Johnson, A. M., & Lukens, J. R. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116232 · Cited by 19
Tiwari, R. K., Moin, A., Rizvi, S. M. D., Shahid, S. M. A., & Bajpai, P. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00696-6 · Cited by 19
Aranđelović, J., Santrač, A., Batinić, B., Todorović, L., Stevanović, V., Tiruveedhula, V. V. N. P. B., Sharmin, D., Rashid, F., Stanojević, B., Cook, J. M., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13914 · Cited by 17
Peak, S. L., Gracia, L., Lora, G., & Jinwal, U. K. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.020 · Cited by 18
Kioussis, B., Tuttle, C. S. L., Heard, D. S., Kennedy, B. K., Lautenschlager, N. T., & Maier, A. B. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101302 · Cited by 19
St‐Amour, I., Bousquet, M., Paré, I., Drouin‐Ouellet, J., Cicchetti, F., Bazin, R., & Calon, F. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-234 · Cited by 17
Microglial apolipoprotein E particles contribute to neuronal senescence and synaptotoxicity
Wang, N., Cai, L., Pei, X., Lin, Z., Huang, L., Liang, C., Wei, M., Shao, L., Guo, T., Huang, F., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110006 · Cited by 18
Importance of Oxidative Stress and Antioxidant System in Health and Disease
Sabuncuoğlu, S., & Yalçınkaya, A. S. (2022) · Biochemistry · doi:10.5772/intechopen.100949 · Cited by 16
Recent insights into viral infections as a trigger and accelerator in alzheimer's disease
Vlieger, L. D., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103340 · Cited by 16
Microglia activated by microbial neuraminidase contributes to ependymal cell death
Fernández‐Arjona, M. D. M., León‐Rodríguez, A., López-Ávalos, M. D., & Grondona, J. M. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00249-0 · Cited by 18
The Role of Immunity in Alzheimer's Disease
McManus, R. M. (2022) · Advanced Biology · doi:10.1002/adbi.202101166 · Cited by 16
Chiarini, A., Armato, U., Hu, P., & Prà, I. D. (2020) · Cells · doi:10.3390/cells9061386 · Cited by 15
Wang, Z., Pang, S., Zhang, K.-W., Li, P., Li, P.-G., & Yang, C. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1367086 · Cited by 15
Refining the interactions between microglia and astrocytes in Alzheimer’s disease pathology
Chen, J., Xu, S., Wang, L., Liu, X., Liu, G., Tan, Q., Li, W., Zhang, S., & Du, Y. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.033 · Cited by 17
Inflammatory Cytokine IL-1β Downregulates Endothelial LRP1 via MicroRNA-mediated Gene Silencing
Hsu, H.-W., Rodríguez‐Ortiz, C. J., Zumkehr, J., & Kitazawa, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.021 · Cited by 16
Self-citationGupta, K., Vishwakarma, J., Garg, A., Pandey, R., Jain, V., Gupta, R., Das, U., Roy, S. K., & Bandyopadhyay, S. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac087 · Cited by 14
Sakakibara, Y., Yamashiro, R., Chikamatsu, S., Hirota, Y., Tsubokawa, Y., Nishijima, R., Takei, K., Sekiya, M., & Iijima, K. (2023) · iScience · doi:10.1016/j.isci.2023.105968 · Cited by 14
Fighting fire with fire: The immune system might be key in our fight against Alzheimer’s disease
Dujardin, P., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.004 · Cited by 14
Ye, L., Wang, Z., Kim, Y., Elias, P. M., Li, T., Wen, S., Song, J., Lv, C., Yang, B., & Man, M. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18162 · Cited by 15
Wendt, S., Lin, A. J., Ebert, S. N., Brennan, D. J., Cai, W., Bai, Y., Kong, D. Y., Sorrentino, S., Groten, C. J., Lee, C., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03433-3 · Cited by 13
Cho, S. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042211 · Cited by 12
The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
Ribarič, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084358 · Cited by 15
IL-1R-/- alleviates cognitive deficits through microglial M2 polarization in AD mice
Wang, H., Peng, G., Wang, B., Yin, H., Fang, X., He, F., Zhao, D., Liu, Q., & Shi, L. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.11.020 · Cited by 13
Spitzer, P., Weinbeer, J., i, M. H., Oberstein, T. J., Condic, M., Lewczuk, P., Kornhuber, J., & Maler, J. M. (2019) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988719841728 · Cited by 14
Lu, Y., Cheng, L., Xiong, Y., Huang, C., Liu, Z., Shen, C., Wang, H., Qiu, Y., Yang, S., Wu, M., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70403 · Cited by 12
Topalis, V., Voros, C., & Ziaka, M. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251361578 · Cited by 14
Gautam, A. S., Panda, E. S., Balki, S., Pandey, S. K., Tiwari, A., & Singh, R. K. (2024) · Food & Function · doi:10.1039/d4fo05278a · Cited by 13
Baranger, K., van Gijsel‐Bonnello, M., Stephan, D., Carpentier, W., Rivera, S., Khrestchatisky, M., Gharib, B., Reggi, M. L. D., & Benech, P. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00754-z · Cited by 13
Tan, F. H., Najimudin, N., Watanabe, N., Shamsuddin, S., & Azzam, G. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114568 · Cited by 10
Myers, J. S., Koleck, T. A., Sereika, S. M., Conley, Y. P., & Bender, C. M. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3654-3 · Cited by 12
Huang, Z. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221042 · Cited by 12
Katsipis, G., Tzekaki, E. E., Andreadou, E. G., Mouzakidis, C., Baldimtsi, E. N., Karathanasi, E. M., Hassandra, M., Galanis, E., Hatzigeorgiadis, A., Γούδας, Μ., et al. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.104085 · Cited by 12
Immune modulations and immunotherapies for Alzheimer’s disease: a comprehensive review
Mahdiabadi, S., Momtazmanesh, S., Perry, G. L., & Rezaei, N. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0092 · Cited by 13
Age-related inflammatory changes and perineuronal net dynamics: implications for aging
Colon, Z. A., Chan, S. C., & Maguire‐Zeiss, K. A. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03568-3 · Cited by 13
Xu, P., Cui, D., Jin, M., & Sun, L. (2024) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2024.100094 · Cited by 12
Guo, L., Zhao, Y., Kong, Z., Liu, R., & Liu, P. (2024) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2024.102404 · Cited by 10
Saaoud, F., Liu, L., Xu, K., Lu, Y., Shao, Y., Issa, M., Jiang, X., Wang, X., Liu, X., Autieri, M. V., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251329583 · Cited by 13
Neuroinflammation to neurodegeneration: Boulevard of broken nerves
Attiq, A., Afzal, S., Raman, H., & Ahmad, W. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115015 · Cited by 12
Ma, L., Wang, X., Li, Y., Xiao, H., & Yuan, F. (2018) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2018.1464948 · Cited by 10
Chauhan, P., Wadhwa, K., & Singh, G. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156109 · Cited by 12
Proteostasis and Neuroinflammation in Alzheimer’s Disease
Potokiri, A., & Wang, H. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin39826 · Cited by 9
Hasantari, I., Nicolas, N., Alzieu, P., Leval, L., Shalabi, A., Grolleau, S., & Dinet, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042272 · Cited by 9
Patient-derived iPSCs, a reliable in vitro model for the investigation of Alzheimer’s disease
Asiamah, E. A., Guo, R., Kong, D., Feng, B., He, J., Zhang, W., Liu, X., Du, X., Ma, Z., Liu, B., et al. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0065 · Cited by 9
Cantone, A. F., Burgaletto, C., Benedetto, G. D., Gaudio, G., Giallongo, C., Caltabiano, R., Broggi, G., Bellanca, C. M., Cantarella, G., & Bernardini, R. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10177-7 · Cited by 10
Sarkar, S., Porel, P., Kosey, S., & Aran, K. R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01697-y · Cited by 9
Role of astroglia and microglia in Alzheimer's disease and multiple therapeutic interventions
Li, L., Wang, Y., Feng, Q., Ma, C., He, C., Wan, W., & Tang, L. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251335572 · Cited by 9
Recent advances in Alzheimer’s disease pathogenesis and therapeutics from an immune perspective
Nguyen, T.-D., Dang, L. N., Jang, J., & Park, S. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00631-0 · Cited by 9
Lim, S., Tran, D. N., Kieu, Z., Chen, C., Villanueva, E., Ghiaar, S., Gallup, V., Zumkehr, J., Cribbs, D. H., Rodríguez‐Ortiz, C. J., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01894-6 · Cited by 8
Self-citationDeletion of MyD88 in astrocytes prevents β‐amyloid‐induced neuropathology in mice
Huat, T. J., Onraet, T., Camats‐Perna, J., Newcombe, E. A., Ngo, K. C., Sue, A. N., Mirzaei, M., LaFerla, F. M., & Medeiros, R. (2022) · Glia · doi:10.1002/glia.24285 · Cited by 8
Self-citationAstrocytes and Inflammatory Processes in Alzheimer’s Disease
Vallés, S. L., Burguet, F., Iradi, A., Aldasoro, M., Vila, J. M., Aldasoro, C., & Jorda, A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88701 · Cited by 9
Anton, P. E., Twardy, S. M., Nagpal, P., Moreno, J. A., Burchill, M. A., Chatterjee, A., Busquet, N., Mesches, M. H., Kovacs, E. J., & McCullough, R. L. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf024 · Cited by 9
Zhang, L., Guan, C., Wang, S., Pfeiffer, N., & Grus, F. (2025) · Antioxidants · doi:10.3390/antiox14030363 · Cited by 8
Modulation of adult hippocampal neurogenesis by interleukin 1 signaling
Smirnova, M. I., & Quan, N. (2025) · Neurobiology of Sleep and Circadian Rhythms · doi:10.1016/j.nbscr.2025.100123 · Cited by 8
Zhao, R., Sophanpanichkul, P., Chadarevian, J. P., Ding, Y., Dai, H., Nayak, M., Davtyan, H., Blurton-Jones, M. M., & Goldstein, S. A. N. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2509903122 · Cited by 7
Xu, G., Guan, P.-P., & Wang, P. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02174-z · Cited by 7
Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein
Quint, W. H., Matečko‐Burmann, I., Schilcher, I., Löffler, T., Schöll, M., Burmann, B. M., & Vogels, T. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201334 · Cited by 7
Ion transporter cascade, reactive astrogliosis and cerebrovascular diseases
Rahman, M. S., Islam, R., & Bhuiyan, M. I. H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1374408 · Cited by 8
Postu, P. A., Tiron, A., Tiron, C. E., Gorgan, L., Mihăşan, M., & Hriţcu, L. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210303111537 · Cited by 7
Zhong, M., Xu, Q., Huang, M., Zhan, R., Huang, X., Yang, W., Lin, Z., & Xian, Y. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01475-0 · Cited by 9
Zeng, X., Yuan, Y., Li, Y., Hu, Z., & Hu, S. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115304 · Cited by 8
Mi, S., Nakashima, H., & Nakashima, K. (2025) · Epigenomes · doi:10.3390/epigenomes9040038 · Cited by 6
Weng, Y., He, T., Li, M., Zhou, Q., Xie, J., Wei, L., Wang, X., Wang, J.-Z., Zhong, M., & Li, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1744375 · Cited by 8
Lin, N., Goh, A., Lin, S., Chuang, K., Chang, C.-H., Li, M., Lu, C.-H., Chen, W., Wei, P.-H., Pan, I.-H., et al. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220056 · Cited by 6
Time-Dependent Long-Term Effect of Memantine following Repetitive Mild Traumatic Brain Injury
Boucher, M. L., Conley, G. M., Morriss, N. J., Ospina-Mora, S., Qiu, J., Mannix, R., & Meehan, W. P., III (2024) · Journal of Neurotrauma · doi:10.1089/neu.2023.0423 · Cited by 6
The role of IL-1 family of cytokines in the pathogenesis and therapy of Alzheimer’s disease
Li, C., Zhang, X., Wang, Y., Cheng, L., Li, C., & Yu, X. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01534-8 · Cited by 6
Solmaz, V., Atasoy, Ö., & Erbaş, O. (2020) · Neurological Research · doi:10.1080/01616412.2020.1747718 · Cited by 6
Pitanga, T. N., Santana, S. S., Zanette, D. L., da Guarda, C. C., Santiago, R. P., Maffili, V. V., Lima, J. B., Carvalho, G. Q., Ribeiro‐Filho, J., Ferreira, J. R. D., et al. (2021) · Inflammation Research · doi:10.1007/s00011-021-01461-2 · Cited by 6
Couch, Y., Davis, A. E. M., Sá-Pereira, I., Campbell, S. J., & Anthony, D. C. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0178-3 · Cited by 6
Li, Z., Tan, B., Dong, K., Yu, X., Zhang, S. W., Luo, L., Yao, W., Qin, Z., & Wu, F. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117779 · Cited by 5
Maeshiba, M., Kajiya, H., Tsutsumi, T., Migita, K., Goto-T, K., Kono, Y., Tsuzuki, T., & Ohno, J. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.048 · Cited by 5
Paul, D., & Basavan, D. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00446-0 · Cited by 5
Tzekaki, E. E., Katsipis, G., Andreadou, E. G., Mouzakidis, C., Baldimtsi, E. N., Karathanasi, E. M., Hassandra, M., Galanis, E., Hatzigeorgiadis, A., Γούδας, Μ., et al. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100090 · Cited by 5
Lavi, E., Maree, A., Eisenstein, E. M., Wexler, I. D., Berger, I., & Berkun, Y. (2021) · Modern Rheumatology · doi:10.1093/mr/roab009 · Cited by 5
Alzheimer’s disease: a step closer to understanding type 3 diabetes in African Americans
Ferguson, S. A., Panos, J., Sloper, D. T., Varma, V., & Sarkar, S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00754-z · Cited by 5
Boosting Neurogenesis as a Strategy in Treating Alzheimer’s Disease
Dwamena, A., Arachchi, R. Y. B., & Wang, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188926 · Cited by 4
Saad, H. M., Atef, E., Aboushouk, A. A., Waheeb, T. S., Elsayed, A., & Mohammed, S. A. A. (2026) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlag014 · Cited by 4
Wang, X., Rong, Z., & Xue, F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27115020 · Cited by 6
Successful treatment of epileptic encephalopathy with spike wave activation in sleep with anakinra
Ng, A. C., & Scantlebury, M. H. (2024) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2024.100678 · Cited by 4
Kassem, I. A. A., Ragab, M. F., Nabil, M., & Melek, F. R. (2020) · Phytochemistry Letters · doi:10.1016/j.phytol.2020.09.007 · Cited by 4
Dadras, S., & Bhaskar, K. (2025) · ASN NEURO · doi:10.1080/17590914.2025.2598310 · Cited by 3
Li, J.-G., Leone, A., Servili, M., & Praticò, D. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241283675 · Cited by 4
Liu, T., & Li, X. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70460 · Cited by 3
OPTN protects retinal ganglion cells and ameliorates neuroinflammation in optic neuropathies
Wang, Q., Wang, Y., Jiang, Y., Donahue, R., Cao, G., Yan, W., Guo, H., Li, Z., Liang, J., Hao, J., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08534-6 · Cited by 3
The Role of Inflammasomes in the Pathogenesis of Neurodegenerative Diseases
Shevchuk, D. V., Abramova, A. A., & Zakharova, M. N. (2022) · Neurochemical Journal · doi:10.1134/s1819712422030114 · Cited by 3
Reactive Astrogliosis and Neuronal Functions of Astrocytes in Neurological Disorders
Mathure, D. M., Kumar, D., Ranpise, H. A., & Awasthi, R. (2024) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.58.2.44 · Cited by 2
VD/VDR-mediated ATG16L1 activation reduces Alzheimer’s disease-like pathology and cognitive decline
Huang, Z., Ang, W., Huang, H., & Wang, Y. (2024) · Molecular & Cellular Toxicology · doi:10.1007/s13273-024-00429-7 · Cited by 3
Ueno, H., Hattori, T., Chi, H.-H., Miyabe, Y., & Murayama, M. A. (2024) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.24-0063 · Cited by 3
Interleukin 1 Receptor and Alzheimer’s Disease-Related Neuroinflammation
Wang, H., & Wang, X. (2017) · InTech eBooks · doi:10.5772/intechopen.69067 · Cited by 4
Orellano, L. A. A., Zeng, C., Zhu, J., Bogyo, M. S., Rock, K. L., & Lai, J. (2026) · Communications Medicine · doi:10.1038/s43856-026-01590-x · Cited by 2
Kokhan, V. S., Levashova, A. I., Nesterov, M. S., Pikalov, V. A., & Chicheva, M. M. (2025) · Biology · doi:10.3390/biology14060682 · Cited by 2
Medeiros, E. B., Lídio, A. V., Zabot, G. C., Fenilli, G. P., Silveira, G. D. B., Keller, G. S., Carrion, F. R. A., Felice, F. G. D., Kluwe‐Schiavon, B., Walss‐Bass, C., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-10927-w · Cited by 3
Li, Q., Zhao, R., Tian, X., & Xu, H. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1780247 · Cited by 2
廉文文, Zhou, F., Tong, Z., 夏聪媛, Yu, Y., He, J., Jiekun, X., & Zhang, W. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103273 · Cited by 2
Gong, M., Lan, J. X., & Miao, J. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1908574 · Cited by 3
Kanuri, S. H. (2024) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-024-00853-5 · Cited by 2
Molecular etiopathogenesis of neurodegenerative diseases
Divya, D., Thekkekkara, D., Sai, T. E., Ramakrishna, D., Manjula, S. N., & Goswami, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00002-7 · Cited by 2
Understanding the neurobiological mechanisms of LPS‑induced memory impairment
Golkar, A., Dalfardi, M., Hedayati‐Moghadam, M., Askarpour, H., Hosseini, M., & Baghcheghi, Y. (2025) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2024-2629 · Cited by 4
Teng, Y., Gao, J., Tan, T., Zhang, X., Wang, Y., Zhang, J., & Ni, L. (2024) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2024.102390 · Cited by 2
Vasconcelos, B., Bird, M., Stancu, I., Terwel, D., & Dewachter, I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00006-3 · Cited by 2
Metadata
- Authors
- Kitazawa, M., Cheng, D., Tsukamoto, M. R., Koike, M. A., Wes, P. D., Vasilevko, V., Cribbs, D. H., & LaFerla, F. M.
- Affiliations
- University of California, Irvine (US)
- Roche Pharmaceuticals , Palo Alto, CA 94304
- Corresponding author
- Kitazawa, Masashi
- Cheng, David
- Vasilevko, Vitaly
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-12
- Volume
- 187
- Issue
- 12
- Pages
- 6539-6549
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4072218
- OpenAlex
- W2129470375
- Cited by
- 473
- References
- 83
- Citations by year
- 2026: 32 · 2025: 42 · 2024: 40 · 2023: 36 · 2022: 43 · 2021: 35 · 2020: 46 · 2019: 31 · 2018: 39 · 2017: 26 · 2016: 30 · 2015: 18 · 2014: 24 · 2013: 17 · 2012: 14
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (4r01ag020241-15)
- National Institute on Aging (P01AG000538, R01AG020335, P50 AG 16573, R01 AG-020241, AG020241, AG 00538, P50AG016573, RF1AG020241, R01AG20335, R01AG021982)
- National Institute of Neurological Disorders and Stroke (NS 050895, R01NS050895)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K99AR054695)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, IL-1β signaling, IL-1 receptor blockade, tau pathology, cognitive impairment, amyloid-beta, NF-κB, tau kinases, GSK3β, CDK5/p25, p38 MAPK, Wnt/β-catenin signaling, S100B, astrocytes, neuroinflammation, 3xTg-AD mice, disease-modifying therapy
- MeSH terms
- Alzheimer Disease, Animals, Cells, Cultured, Cognition Disorders, Disease Models, Animal, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Nerve Growth Factors, S100 Proteins, Neurons, Signal Transduction, NF-kappa B, tau Proteins, Receptors, Interleukin-1, Cell Line, Tumor, beta Catenin, Mice, Interleukin-1beta, S100 Calcium Binding Protein beta Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
